Marc Pelletier

Marc Pelletier

Company: Novartis

Job title: Senior Principal Scientist - Translational Immune Oncology


Targeting IL-1b Pathway for Cancer Immunotherapy 8:30 am

IL1b blockade was shown to inhibit chronic inflammation and prevent occurrence of lung cancer in a susceptible population Single cell RNAseq analysis of primary tumor samples with in vitro treatment highlight cell targets and pathways for MoA Mouse tumor models show a shift from immune suppression to activation with IL1b blockadeRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.